Sarepta Gene Therapy Setbacks

Order byBest matchMost fresh

Sarepta, Gene Therapy

Sarepta's Setback Deepens With Another Gene Therapy Fatality

In response to these safety concerns, the U.S Food and Drug Administration (FDA) has requested that the label include a black box warning for acute liver injury (ALI) and acute liver failure (ALF), a...

STAT · 1d

Pharmalittle: We’re reading about a GSK setback, another Sarepta gene therapy death, and more

· 6h

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request

· 1d

Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says

The U.S. Food and Drug Administration is planning to request Sarepta Therapeutics (SRPT.O) to voluntarily stop all shipments of its gene therapy, Elevidys, a source familiar with the matter told Reut...

· 1d

FDA to ask Sarepta to stop shipping Duchenne gene therapy

· 1d

Sarepta Therapeutics crisis is huge blow to Duchenne families, company

Mankato Free Press36m

Ask Us: City addresses flooded ballfields, setbacks for apartment buildings

Q: We just drove through Sibley Park and noticed that nothing has been done with the softball fields that were affected by the flooding last year, just wondering what the

3don MSN

Sarepta to cut 500 jobs after gene therapy setback, shares jump

Sarepta Therapeutics said on Wednesday it would lay off 36% of its workforce, or about 500 employees, after the recent deaths of two patients who had received its gene therapy Elevidys. Its shares shot up about 40% in extended trading,